当前位置: X-MOL 学术Lancet Infect Dis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Alternative hepatitis B vaccine strategies in healthy non-responders to a first standard vaccination scheme.
The Lancet Infectious Diseases ( IF 56.3 ) Pub Date : 2019-10-16 , DOI: 10.1016/s1473-3099(19)30582-1
Paul Loubet 1 , Odile Launay 1
Affiliation  

Hepatitis B virus (HBV) infection is a major public health problem with an estimated 257 million people with chronic HBV infection and around 650 000 annual deaths due to long-term HBV-related liver disease (cirrhosis and hepatocellular carcinoma). Vaccination represents the cornerstone of public health measures to eradicate HBV. The implementation of effective infant vaccination programmes in many countries has resulted in a significant decrease in the prevalence of HBV infection and in the incidence of liver cancer in children and young adults.

中文翻译:

对第一标准疫苗接种计划无反应的健康无反应者的替代乙肝疫苗策略。

乙型肝炎病毒(HBV)感染是一个重大的公共卫生问题,由于长期HBV相关的肝病(肝硬化和肝细胞癌),估计有2.57亿人患有慢性HBV感染,每年约有65万人死亡。疫苗接种是消除HBV的公共卫生措施的基石。在许多国家实施有效的婴儿疫苗接种计划已导致儿童和年轻人中HBV感染的流行率和肝癌发生率显着下降。,  , 
更新日期:2019-12-25
down
wechat
bug